Related references
Note: Only part of the references are listed.Effect of Obesity on Prognosis After Early-Stage Breast Cancer
Marianne Ewertz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors
Karen J. Wernli et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Lipophilic Statin Use and Risk of Breast Cancer Subtypes
Stephan Woditschka et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Statin Use and Risk of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Henrik Toft Sorensen et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies
Jaclyn L. F. Bosco et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Yasuyuki Matsushita et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Danish Breast Cancer Cooperative Group - DBCG: History, organization, and status of scientific achievements at 30-year anniversary
Mogens Blichert-Toft et al.
ACTA ONCOLOGICA (2008)
The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise
Susanne Moller et al.
ACTA ONCOLOGICA (2008)
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: Impact of the 2001 National Cholesterol Education Program guidelines
Devin Mann et al.
ANNALS OF PHARMACOTHERAPY (2008)
Renin-anglotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer
Ronald van der Knaap et al.
CANCER (2008)
Statin use and prostate cancer risk in a large population-based setting
Denise M. Boudreau et al.
CANCER CAUSES & CONTROL (2008)
Prediagnostic use of hormone therapy and mortality after breast cancer
Polly A. Newcomb et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users
Anjali S. Kumar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Use of common medications and breast cancer risk
Kirsten B. Moysich et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Statins and cancer: a meta-analysis of case-control studies
Marcia L. Taylor et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Chao-Yung Wang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors
Hakan Harputluoglu et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients
Gary D. Friedman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
NSAIDs and breast cancer recurrence in a prospective cohort study
Marilyn L. Kwan et al.
CANCER CAUSES & CONTROL (2007)
Statins and risk of cancer: A systematic review and metaanalysis
Danielle R. L. Browning et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer
Henry K. Tsai et al.
UROLOGY (2006)
Breast cancer growth prevention by statins
Michael J. Campbell et al.
CANCER RESEARCH (2006)
Statin use and breast cancer: Prospective results from the Women's Health Initiative
JA Cauley et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
A call for clinical trials: Lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes
AS Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Statins and cancer risk - A meta-analysis
KM Dale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies
S Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Serum lipids, lipid-lowering drugs, and the risk of breast cancer
AH Eliassen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer
MS Katz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Cancer risk among statin users: A population-based cohort study
S Friis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Therapy Insight: potential of statins for cancer chemoprevention and therapy
MS Katz
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Update on statins: 2003
CJ Vaughan et al.
CIRCULATION (2004)
Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors
T Kubota et al.
BIOCHEMICAL PHARMACOLOGY (2004)
The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women - A case-control study
DM Boudreau et al.
CANCER (2004)
Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark
AR Jensena et al.
EUROPEAN JOURNAL OF CANCER (2003)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism
S Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
